Cytodyn
Biotechnology company focused on the development of new therapies to combat infections with immune deficiency viruses.
Launch date
Employees
Market cap
CAD248m
Enterprise valuation
CAD285m (Public information from Sep 2024)
Share price
$0.16 CYDY
Lake Oswego Oregon (HQ)
Authorizing premium user...